Fasken Martineau DuMoulin LLP advised Research Capital Corporation on the matter. GeneTether Therapeutics Inc. (CSE: GTTX), an innovative genetic medicines company, completed an initial public offering of…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Sonia Carcano
…
This content is for Standard 1 Year members only. LoginJoin Now